Analysis of 13 TP53 and WRAP53 polymorphism frequencies in russian populations
暂无分享,去创建一个
[1] R. Scott,et al. Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population , 2020, Breast Cancer.
[2] Davoud Farajzadeh,et al. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer , 2019, PloS one.
[3] Sofie Bergstrand,et al. The Cajal Body Protein WRAP53β Prepares the Scene for Repair of DNA Double-Strand Breaks by Regulating Local Ubiquitination , 2019, Front. Mol. Biosci..
[4] R. Catarino,et al. TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer. , 2018, Oncology letters.
[5] S. Bojesen,et al. TP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals , 2017, Scientific Reports.
[6] S. Böhm,et al. Phosphorylation of the Cajal body protein WRAP53β by ATM promotes its involvement in the DNA damage response , 2016, RNA biology.
[7] S. Farber-Katz,et al. Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes , 2016, International journal of breast cancer.
[8] J. Bourdon,et al. p53 Isoforms: Key Regulators of the Cell Fate Decision. , 2016, Cold Spring Harbor perspectives in medicine.
[9] H. Rassoolzadeh. Unwrapping the role of WRAP53β in DNA damage response , 2016 .
[10] О. П. Балановский,et al. Популяционные биобанки: принципы организации и перспективы применения в геногеографии и персонализированной медицине , 2016 .
[11] C. Méndez-Vidal,et al. Wrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage. , 2016, Molecular cell.
[12] M. Farnebo,et al. On the road with WRAP53β: guardian of Cajal bodies and genome integrity , 2015, Front. Genet..
[13] Z. Ruan,et al. Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism , 2015, PloS one.
[14] J. Bourdon,et al. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective , 2013, OncoTargets and therapy.
[15] S. Mahmoudi. WRAP53 Unwrapped; Roles in Nuclear Architecture and Cancer , 2011 .
[16] L. Henríquez-Hernández,et al. Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy. , 2010, Cancer epidemiology.
[17] M. Farnebo. Wrap53, a novel regulator of p53 , 2009, Cell cycle.
[18] D. Hua,et al. Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy , 2008, Journal of Cancer Research and Clinical Oncology.
[19] R. Catarino,et al. TP 53 Arg 72 Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese / Caucasian patients with advanced cervical cancer , 2022 .